BR112018068939A2 - oclusão de vazamento de fluido cérebro-espinhal - Google Patents

oclusão de vazamento de fluido cérebro-espinhal

Info

Publication number
BR112018068939A2
BR112018068939A2 BR112018068939A BR112018068939A BR112018068939A2 BR 112018068939 A2 BR112018068939 A2 BR 112018068939A2 BR 112018068939 A BR112018068939 A BR 112018068939A BR 112018068939 A BR112018068939 A BR 112018068939A BR 112018068939 A2 BR112018068939 A2 BR 112018068939A2
Authority
BR
Brazil
Prior art keywords
cerebrospinal fluid
self
fluid leak
fluid leakage
assembling peptide
Prior art date
Application number
BR112018068939A
Other languages
English (en)
Portuguese (pt)
Inventor
Kobayashi Satoru
Original Assignee
3 D Matrix Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 3 D Matrix Ltd filed Critical 3 D Matrix Ltd
Publication of BR112018068939A2 publication Critical patent/BR112018068939A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0031—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/03—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/108—Specific proteins or polypeptides not covered by groups A61L24/102 - A61L24/106
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/06—Flowable or injectable implant compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/36—Materials or treatment for tissue regeneration for embolization or occlusion, e.g. vaso-occlusive compositions or devices
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dispersion Chemistry (AREA)
  • Materials Engineering (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
BR112018068939A 2016-03-18 2017-03-17 oclusão de vazamento de fluido cérebro-espinhal BR112018068939A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662310122P 2016-03-18 2016-03-18
PCT/IB2017/000387 WO2017158435A1 (en) 2016-03-18 2017-03-17 Cerebrospinal fluid leakage occlusion

Publications (1)

Publication Number Publication Date
BR112018068939A2 true BR112018068939A2 (pt) 2019-01-22

Family

ID=58645333

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018068939A BR112018068939A2 (pt) 2016-03-18 2017-03-17 oclusão de vazamento de fluido cérebro-espinhal

Country Status (9)

Country Link
US (1) US20210023257A1 (enExample)
EP (1) EP3429645A1 (enExample)
JP (1) JP2019508181A (enExample)
CN (1) CN109195640A (enExample)
AU (1) AU2017232550A1 (enExample)
BR (1) BR112018068939A2 (enExample)
CL (1) CL2018002643A1 (enExample)
MX (1) MX2018011201A (enExample)
WO (1) WO2017158435A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3017684A1 (en) 2016-03-18 2017-09-21 3-D Matrix, Ltd. Preventing biological tissue adhesion
JP7335025B2 (ja) 2020-03-31 2023-08-29 株式会社スリー・ディー・マトリックス 照射による自己組織化ペプチドの滅菌

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9162005B2 (en) * 2005-04-25 2015-10-20 Arch Biosurgery, Inc. Compositions for prevention of adhesions and other barrier applications
EP1879606B1 (en) * 2005-04-25 2013-06-12 Massachusetts Institute of Technology Self-assembling peptides for promoting hemostasis
US7854923B2 (en) * 2006-04-18 2010-12-21 Endomedix, Inc. Biopolymer system for tissue sealing
CN101472620A (zh) * 2006-04-25 2009-07-01 麻省理工学院 用于影响污染物、机体流体或其它实体移动和/或影响其它生理状况的组合物和方法
ES2821436T3 (es) * 2008-10-06 2021-04-26 3 D Matrix Ltd Tapón de tejidos
CN103800941B (zh) * 2012-11-09 2015-04-22 北京银河巴马生物技术股份有限公司 一种i型胶原材料、脑膜或脊膜生物膜片及其制备方法和应用
JP2016501066A (ja) * 2012-11-14 2016-01-18 株式会社スリー・ディー・マトリックス 血管塞栓システム
EP2968654A1 (en) * 2013-03-14 2016-01-20 3-D Matrix, Ltd Treatment for bile leakage

Also Published As

Publication number Publication date
WO2017158435A1 (en) 2017-09-21
AU2017232550A1 (en) 2018-09-27
JP2019508181A (ja) 2019-03-28
EP3429645A1 (en) 2019-01-23
US20210023257A1 (en) 2021-01-28
CN109195640A (zh) 2019-01-11
CL2018002643A1 (es) 2019-04-26
MX2018011201A (es) 2018-11-22

Similar Documents

Publication Publication Date Title
BR112018068838A2 (pt) oclusão de fístula pancreática
BR112015022747A2 (pt) materiais de prevenção de obstrução gastrointestinal
CL2020002012A1 (es) Formulaciones de anticuerpos humanos anti-rankl y métodos de uso de estas. (divisional solicitud 201903032)
EP3337782A4 (en) DIACEREIN OR ITS ANALOGUE FOR INHIBITING THE EXPRESSION OF ASC, NLRP3 AND / OR FOR THE FORMATION OF NLRP3 INFLAMMASOM COMPLEX
BR112014024287A2 (pt) composições e métodos para a prevenção e tratamento do derrame vascular induzido por mastócitos
HRP20191254T1 (hr) Peptidi koji prodiru u stanice i postupci za njihovu proizvodnju i uporabu
EA201690753A1 (ru) Комбинации ингибиторов гистондеацетилазы и иммуномодулирующих лекарственных средств
BR112017008165A2 (pt) anticorpos de domínio único direcionados contra antígenos intracelulares
IL272593A (en) Methods of treatment of osteoarthritis with transdermal cannabidiol gel
PE20170140A1 (es) Metodos para tratar el cancer con inhibidores de tigit y agentes contra el cancer
IL254529A0 (en) Combination of hdac inhibitor and anti-pd-1 antibody for treatment of cancer
BR112017005817A2 (pt) sistema de compressão
WO2016112208A3 (en) Topical applications of kv1.3 channel blocking peptides to treat skin inflammation
EP3768266A4 (en) OXO-TETRAHYDRO-ISOCHINOLINE-CARBOXYLIC ACIDS AS STING INHIBITORS
HK1220145A1 (zh) 胆漏治疗
EP3406270A4 (en) SURGICAL SEALANT
AR120721A2 (es) Péptidos y composiciones para el tratamiento de daño articular
MX2020001423A (es) Composiciones capilares para el tratamiento de daños.
BR112018068939A2 (pt) oclusão de vazamento de fluido cérebro-espinhal
BR112018068941A2 (pt) prevenção de adesão de tecidos biológicos
MX2019005979A (es) Peptidos modificados.
BR112018008840A8 (pt) anticorpos de domínio único direcionados contra antígenos intracelulares
BR112016023519A2 (pt) inibidor de sinalização de wnt/ß-catenina, composição farmacêutica e método de tratamento e/ou prevenção de uma patologia definida por malformação vascular
BR112018068027A2 (pt) método para tratar câncer em um paciente e composição farmacêutica
BR112015023383A2 (pt) compostocomposição farmacêutica; e método de modulação

Legal Events

Date Code Title Description
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements